WeVote

Bill

Bill

H 29

UNIFORM CONTROLLED SUBSTANCES – Amends existing law to revise provisions regarding controlled substances.

68th Legislature, 1st Regular Session (2025)

House Bill 29 updates Idaho's drug classifications to combat synthetic substance abuse, enhancing public health and guiding healthcare and law enforcement practices.

Reported Signed by Governor on February 26, 2025 Session Law Chapter 8 Effective: 07/01/2025
0
WeVote Research Nonpartisan
Bill Summary · H 29

Summary of House Bill 29: Uniform Controlled Substances

Bill Number: H 29
Title: Uniform Controlled Substances
Status: Reported Signed by Governor on February 26, 2025
Effective Date: July 1, 2025
Introduced: January 21, 2025
Classification: Bill
Subject Areas: Controlled Substances, Criminal Offenses and Procedures, Health, Health Care Facilities, Health Care Professions and Providers, Medical

Purpose and Intent

House Bill 29 aims to update the Idaho Controlled Substance Act by revising the classifications of certain controlled substances. The primary intent is to enhance public health and safety by addressing the growing concerns surrounding synthetic drugs and substances that pose significant risks without approved medical uses.

Key Provisions

The bill includes the following significant amendments:

  1. Addition to Schedule I:

    • The bill adds several benzodiazepine derivatives, synthetic fentanyls, and synthetic cannabinoids that have no approved medical use to Schedule I. This classification indicates that these substances are considered to have a high potential for abuse and no accepted medical use.
  2. Addition to Schedule III:

    • Several synthetic anabolic steroids are added to Schedule III, which includes substances that have accepted medical uses but also a potential for abuse.
  3. Addition to Schedule IV:

    • A new FDA-approved treatment for post-partum depression is included in Schedule IV, indicating it has accepted medical uses and a lower potential for abuse compared to substances in Schedules I and II.

Impact

  • Public Health and Safety: The bill is designed to combat the misuse of dangerous synthetic substances, thereby potentially reducing health risks associated with their abuse.
  • Healthcare Providers: Medical professionals will need to be aware of the updated classifications to ensure compliance with prescribing regulations.
  • Law Enforcement: The bill will assist law enforcement agencies in regulating and controlling the distribution of newly classified substances.

Fiscal Note

The legislation is projected to have no financial impact on the state’s General Fund or any dedicated or federal funds, indicating that the implementation of these changes will not require additional state funding.

Legislative Timeline

  • January 21, 2025: Bill introduced and referred to the Health & Welfare Committee.
  • February 10, 2025: Passed the House with a vote of 70-0.
  • February 18, 2025: Passed the Senate with a vote of 35-0.
  • February 26, 2025: Signed by the Governor.
  • July 1, 2025: Effective date of the bill.

Conclusion

House Bill 29 represents a proactive approach to managing the risks associated with controlled substances in Idaho. By updating the classifications of certain drugs, the bill aims to protect public health while providing clear guidelines for healthcare providers and law enforcement.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.